Report - A Phase II Trial of Ibudilast in Progressive Multiple ... · NN102 / SPRINT-MS Trial Overview • 96-week, 28-site, phase II trial utilizing NIH-sponsored NeuroNEXT network • Inclusion:

Please pass captcha verification before submit form